SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The S&P 500 is seeing significant upward pressure as investors react to potential de-escalation in Middle East geopolitical tensions and cooling oil prices. The community is actively debating the sustainability of this overnight pump, with many retail traders questioning if this is a genuine recovery or another bull trap designed to flush out bearish positions.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing is capturing market attention as fresh federal executive orders accelerate the national quantum technology strategy, driving optimism for the broader sector. While the community is actively debating the stock's long-term potential, discussion remains polarized between investors focused on government-linked catalysts and skeptics wary of persistent insider selling and high cash burn.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is facing significant downward pressure as investors rotate out of high-valuation quantum stocks, leading to heavy short-selling activity and bearish sentiment regarding current entry points. Despite the short-term volatility, the community remains divided, with long-term investors pointing to IonQ's trapped-ion technical leadership and government partnerships as fundamental catalysts for eventual recovery.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is facing a pivotal week as investors await briefing documents ahead of the FDA Advisory Committee meeting for Deramiocel. The community is focused on the potential for a broad label approval for Duchenne muscular dystrophy, with significant discussion revolving around intense short interest and the strategic importance of this data in securing a landmark treatment for patients.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is surging as investors react to a significant jump in liquefaction fees and a tightening global LNG market, fueled by ongoing geopolitical tensions and energy supply disruptions in the Strait of Hormuz. Community sentiment remains focused on the company's long-term production growth and potential earnings beats, with traders actively debating whether the current upward momentum can overcome persistent short-selling pressure and market-maker volatility.

Amkor Technology, Inc. engages in the provision of outsourced semiconductor packaging and test services. Its services include design, package characterization, test, and wafer bumping services. The company was founded in 1968 and is headquartered in Tempe, AZ.

AMKOR Technology Inc.

AMKR is attracting significant investor attention as a key player in the semiconductor advanced packaging supply chain, with community sentiment fueled by its strategic partnerships with major AI chip designers like NVIDIA, AMD, and TSMC. Traders are closely monitoring the upcoming earnings season for confirmation of the company's growth trajectory and its ability to capitalize on the ongoing demand for high-performance AI infrastructure.

SK hynix, Inc. engages in the manufacture and sale of semiconductor products. Its products include dynamic random access memory, flash memory, complementary metal oxide semiconductor image sensor, and others. The company was founded on October 15, 1949 and is headquartered in Icheon, South Korea.

SK Hynix Inc - ADR

SK Hynix is trending following a massive multi-billion dollar partnership with NVIDIA to supply next-generation HBM memory for AI infrastructure. The community is actively debating the stock's valuation, the significance of the ADR premium compared to domestic Korean shares, and potential arbitrage opportunities following upcoming conversion milestones.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as investors react to the company's deepening integration with NVIDIA's Physical AI and robotics ecosystems, alongside strong performance in QNX-powered safety-critical infrastructure. The community is actively discussing imminent contract announcements, particularly surrounding the Alloy Kore platform, which many believe will significantly scale revenue as automotive and industrial partners standardize their software stacks.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently experiencing intense volatility and downward pressure as investors weigh underwhelming earnings against long-term, high-cost investments in AI, robotics, and autonomy. The community remains deeply divided, with some traders anticipating a short-squeeze reversal while others warn of further technical breakdowns driven by concerns over margin compression and the company's aggressive capital spending.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is currently a focal point for investors as the quantum computing sector gains momentum from high-level government initiatives and strategic policy support. Community discussion is heavily divided between those highlighting recent partnership announcements and hardware milestones as long-term catalysts, and skeptics who are voicing concerns over corporate leadership share sales, valuation metrics, and the volatility inherent in speculative growth stocks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is Allarity Therapeutics, Inc. (ALLR) Outperforming Other Medical Stocks This Year?

Here is how Allarity Therapeutics, Inc. (ALLR) and Alterity Therapeutics Limited - Sponsored ADR (ATHE) have performed compared to their sector so far this year.

Alterity Therapeutics Advances Lead Drug Towards Pivotal Study For Rare Neuromuscular Disorder

Alterity Therapeutics advances ATH434 toward Phase 3 after FDA alignment on trial design for MSA, while shares decline in premarket trading.read more...

Alterity Therapeutics Gets Positive FDA Feedback On ATH434 Phase 3 Study

(RTTNews) - Alterity Therapeutics Limited (ATHE) on Monday said it received positive feedback from the U.S. Food and Drug Administration following a Type C meeting regarding its planned Phase 3 program for ATH434 in Multiple System Atrophy (MSA...

Alterity Therapeutics Gains FDA Backing For Phase 3 MSA Trial

(RTTNews) - Alterity Therapeutics (ATHE, ATH.AX) announced that it has received positive regulatory feedback following a Type C Meeting with the U.S. Food and Drug Administration (FDA) regarding its planned Phase 3 development program for ATH434 in Multiple System Atrophy (MSA...

Alterity Therapeutics Announces Appointment Of Daniel Claassen As Chief Medical Advisor

(RTTNews) - Alterity Therapeutics Limited (ATHE), Wednesday announced the appointment of Daniel Claassen as Chief Medical Advisor, effective March 2026...

Alterity Therapeutics Stock Doubles Premarket On Positive MSA Trial Results: Retail Excitement Soars

Equity

A 50mg dose of its ATH434 showed 8% reduction in clinical progression of early-stage multiple system atrophy vs. placebo.  

Alterity Therapeutics Ltd. is a clinical stage biotechnology company. It engages in the business of research and development of therapeutic drugs designed to treat the underlying cause of degeneration of the brain focusing on Alzheimer's, Huntington, Parkinson’s, and other neurological disorders. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Melbourne, Australia.

Alterity Therapeutics Ltd - ADR

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$4.54
Prev Close	$4.69
Open	$4.66
Dividend Yield	0.00%
50-Day Moving Average	$4.66
Beta	0.89
Avg. Volume	101,844.97
PE Ratio	-0.24

52-Week High	$6.03
52-Week Low	$2.66
Market Capitalization	$82.34M
EPS (Annual)	-$0.7383
Price to Book	0.05
Revenue Per Employee	$0.00

Feed

News

Sentiment

Fundamentals

Info

ATHEAlterity Therapeutics Ltd - ADR

Latest ATHE News